AQR Capital Management’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-42,087
| Closed | -$1.01M | – | 2338 |
|
|
2021
Q1 | $1.01M | Sell |
42,087
-87,842
| -68% | -$2.1M | ﹤0.01% | 1546 |
|
|
2020
Q4 | $1.9M | Buy |
129,929
+5,112
| +4% | +$74.6K | ﹤0.01% | 1189 |
|
|
2020
Q3 | $1.77M | Buy |
124,817
+65,920
| +112% | +$936K | ﹤0.01% | 1163 |
|
|
2020
Q2 | $866K | Buy |
+58,897
| New | +$866K | ﹤0.01% | 1511 |
|
|
2020
Q1 | – | Sell |
-43,420
| Closed | -$209K | – | 2208 |
|
|
2019
Q4 | $209K | Sell |
43,420
-82,446
| -66% | -$397K | ﹤0.01% | 2003 |
|
|
2019
Q3 | $763K | Buy |
125,866
+83,656
| +198% | +$507K | ﹤0.01% | 1602 |
|
|
2019
Q2 | $274K | Buy |
42,210
+30,403
| +257% | +$197K | ﹤0.01% | 1898 |
|
|
2019
Q1 | $84K | Buy |
+11,807
| New | +$84K | ﹤0.01% | 2139 |
|
|
2017
Q4 | – | Sell |
-23,204
| Closed | -$223K | – | 2295 |
|
|
2017
Q3 | $223K | Sell |
23,204
-16,649
| -42% | -$160K | ﹤0.01% | 2151 |
|
|
2017
Q2 | $471K | Buy |
39,853
+6,534
| +20% | +$77.2K | ﹤0.01% | 1912 |
|
|
2017
Q1 | $427K | Buy |
33,319
+17,901
| +116% | +$229K | ﹤0.01% | 1931 |
|
|
2016
Q4 | $189K | Buy |
+15,418
| New | +$189K | ﹤0.01% | 2159 |
|
|
2014
Q4 | – | Sell |
-12,094
| Closed | -$108K | – | 2665 |
|
|
2014
Q3 | $108K | Buy |
12,094
+400
| +3% | +$3.57K | ﹤0.01% | 2437 |
|
|
2014
Q2 | $158K | Sell |
11,694
-8,900
| -43% | -$120K | ﹤0.01% | 2411 |
|
|
2014
Q1 | $205K | Sell |
20,594
-2,800
| -12% | -$27.9K | ﹤0.01% | 2429 |
|
|
2013
Q4 | $311K | Hold |
23,394
| – | – | ﹤0.01% | 2274 |
|
|
2013
Q3 | $284K | Buy |
+23,394
| New | +$284K | ﹤0.01% | 2238 |
|